RHOT1 and neoplasm: While these data reinforce a role of mitochondrial metabolism as an important driver of tumour progression4, molecules in the SNPH pathway exploited in cancer, including KIF5B and Miro1 are druggable, opening fresh therapeutic opportunities to oppose metastatic dissemination in patients.